Abstract
Although osteoporosis is usually associated with women, 1 in 12 men in the UK have the disease, and a third of these cases are idiopathic. Estrogen is now known to be associated with bone loss in older men, but we found, previously, that levels of this hormone were normal in younger cases of male idiopathic osteoporosis (MIO) in the age range 33–61 years. We therefore hypothesized that their estrogen responses in bone might be defective, through impaired estrogen receptor-α (ER)-α expression. Consequently, in the present study, we compared expression of ER-α by indirect immunofluorescence, semiquantitative image analysis, and in situ reverse transcription-polymerase chain reaction in bone sections from MIO patients (33–56 years) (N = 7); age-matched control men (N = 7); and, for reference, ovarian steroid (OS)-replete (N = 7) and OS-deficient women (N = 6). In the control men, 23 ± 6% (mean ± SEM) of osteoblasts and 14 ± 2% of osteocytes expressed ER-α protein, similar to OS-replete women. Although receptor expression decreased in OS-deficient women, the loss of ER-α protein in MIO patients was more severe (1 ± 0.5% osteocytes, 2 ± 1% osteoblasts expressed receptor); however, ER-α messenger RNA (mRNA) was still expressed in controls and MIO patients. Bone loss in these patients may be due to deficient ER-α protein expression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.